{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:48:14Z","timestamp":1792036094759,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019867","name":"Universidad Cooperativa de Colombia","doi-asserted-by":"publisher","award":["INV3458"],"award-info":[{"award-number":["INV3458"]}],"id":[{"id":"10.13039\/501100019867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005278","name":"Universidad de Antioquia","doi-asserted-by":"publisher","award":["64770"],"award-info":[{"award-number":["64770"]}],"id":[{"id":"10.13039\/501100005278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.placenta.2025.04.026","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:53:18Z","timestamp":1746795198000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Maternal serum heparan sulfate in preeclampsia pathophysiology: Insights from a systematic review and meta-analysis"],"prefix":"10.1016","volume":"173","author":[{"given":"Alejandra Mar\u00eda","family":"G\u00f3mez-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Mar\u00eda","family":"Alvarez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Quintana-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5914-7136","authenticated-orcid":false,"given":"Julio Cesar","family":"Bueno-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter D.","family":"Cardona Maya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2025.04.026_bib1","series-title":"StatPearls","article-title":"Preeclampsia","author":"Karrar","year":"2022"},{"issue":"2","key":"10.1016\/j.placenta.2025.04.026_bib2","first-page":"99","article-title":"Non-obstetric complications in preeclampsia","volume":"18","author":"Pankiewicz","year":"2019","journal-title":"Menopause Review\/Przegl\u0105d Menopauzalny"},{"key":"10.1016\/j.placenta.2025.04.026_bib3","first-page":"e21","article-title":"Adverse pregnancy and perinatal outcomes in Latin America and the Caribbean: systematic review and meta-analysis","volume":"46","author":"Blanco","year":"2023","journal-title":"Rev. Panam. Salud P\u00fablic"},{"issue":"6","key":"10.1016\/j.placenta.2025.04.026_bib4","first-page":"e237","article-title":"Number 222","volume":"135","year":"2020","journal-title":"Obstet. Gynecol."},{"issue":"2S","key":"10.1016\/j.placenta.2025.04.026_bib5","doi-asserted-by":"crossref","first-page":"S1019","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2025.04.026_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.placenta.2025.04.026_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091198","article-title":"Risk factors of pre-eclampsia\/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis","volume":"9","author":"Bilano","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.placenta.2025.04.026_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1083\/jcb.200212083","article-title":"QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling","volume":"162","author":"Ai","year":"2003","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.placenta.2025.04.026_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/biom11010029","article-title":"Glycosaminoglycans in tissue engineering: a review","volume":"11","author":"Sodhi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.placenta.2025.04.026_bib10","series-title":"Essentials of Glycobiology","article-title":"Proteoglycans and sulfated glycosaminoglycans","author":"Merry","year":"2022"},{"issue":"1","key":"10.1016\/j.placenta.2025.04.026_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/joim.12465","article-title":"The glycocalyx and its significance in human medicine","volume":"280","author":"Tarbell","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.placenta.2025.04.026_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1134\/S0006297913070055","article-title":"Heparan sulfate-protein binding specificity","volume":"78","author":"Nugent","year":"2013","journal-title":"Biochemistry (Mosc.)"},{"issue":"4","key":"10.1016\/j.placenta.2025.04.026_bib13","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1002\/j.2040-4603.2022.tb00232.x","article-title":"Endothelial glycocalyx","volume":"12","author":"Foote","year":"2022","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.placenta.2025.04.026_bib14","series-title":"Endothelial Dysfunction\u2014Old Concepts and New Challenges","first-page":"113","article-title":"Endothelial dysfunction as a consequence of endothelial glycocalyx damage: a role in the pathogenesis of preeclampsia","author":"Ziganshina","year":"2018"},{"issue":"7","key":"10.1016\/j.placenta.2025.04.026_bib15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/10518","article-title":"Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis","volume":"5","author":"Vlodavsky","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.placenta.2025.04.026_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2014.07.023","article-title":"Evaluation of glycosaminoglycans and heparanase in placentas of women with preeclampsia","volume":"437","author":"Fama","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.placenta.2025.04.026_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yexmp.2012.01.008","article-title":"Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy","volume":"92","author":"Palei","year":"2012","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.placenta.2025.04.026_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jcla.20295","article-title":"Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy","volume":"23","author":"Montagnana","year":"2009","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.placenta.2025.04.026_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1081\/PRG-200059836","article-title":"MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia","volume":"24","author":"Myers","year":"2005","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.placenta.2025.04.026_bib20","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.placenta.2025.04.026_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.placenta.2025.04.026_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jri.2014.02.004","article-title":"Fibrinogen, an endogenous ligand of Toll-like receptor 4, activates monocytes in pre-eclamptic patients","volume":"103","author":"Al-Ofi","year":"2014","journal-title":"J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.placenta.2025.04.026_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-82972-0","article-title":"Soluble syndecan-1 and glycosaminoglycans in preeclamptic and normotensive pregnancies","volume":"11","author":"Hassani Lahsinoui","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.placenta.2025.04.026_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ajog.2022.03.048","article-title":"Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy","volume":"227","author":"Palomo","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2025.04.026_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010647","article-title":"Early onset preeclampsia is associated with glycocalyx degradation and reduced microvascular perfusion","volume":"8","author":"Weissgerber","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.placenta.2025.04.026_bib26","first-page":"e1","article-title":"Gynecologists, gestational hypertension and preeclampsia: ACOG practice bulletin","volume":"133","author":"Obstetricians","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2025.04.026_bib27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/HYPERTENSIONAHA.107.108837","article-title":"Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia","volume":"51","author":"LaMarca","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2025.04.026_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00018-015-2069-x","article-title":"Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia","volume":"73","author":"Roland","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.placenta.2025.04.026_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.placenta.2021.05.002","article-title":"Syncytiotrophoblast stress in early onset preeclampsia: the issues perpetuating the syndrome","volume":"113","author":"Carrasco-Wong","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2025.04.026_bib30","doi-asserted-by":"crossref","unstructured":"C.B. Kirn-Safran, S.S. D'Souza, D.D. Carson, Heparan Sulfate Proteoglycans and Their Binding Proteins in Embryo Implantation and Placentation, Elsevier, pp. 187-193.","DOI":"10.1016\/j.semcdb.2007.07.013"},{"issue":"10","key":"10.1016\/j.placenta.2025.04.026_bib31","article-title":"Overexpression of heparanase is associated with preeclampsia by inhibiting invasion of trophocytes","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.placenta.2025.04.026_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BST0390393","article-title":"Urinary glycan markers for disease","volume":"39","author":"Alonzi","year":"2011","journal-title":"Biochem. Soc. Trans."},{"issue":"10","key":"10.1016\/j.placenta.2025.04.026_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105798","article-title":"Proteoglycans: Systems-level insight into their expression in healthy and diseased placentas","volume":"23","author":"Oravecz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.placenta.2025.04.026_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157608","article-title":"Low soluble syndecan-1 precedes preeclampsia","volume":"11","author":"Gandley","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.placenta.2025.04.026_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1515\/cclm-2019-0686","article-title":"Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: a nested case control study","volume":"58","author":"Kuessel","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.placenta.2025.04.026_bib36","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/HJH.0b013e328344a82c","article-title":"Preeclampsia leads to dysregulation of various signaling pathways in placenta","volume":"29","author":"Kang","year":"2011","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.placenta.2025.04.026_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1515\/jpm-2013-0097","article-title":"Placental syndecan-1 and sulphated glycosaminoglycans are decreased in preeclampsia","volume":"42","author":"Heyer-Chauhan","year":"2014","journal-title":"J. Perinat. Med."},{"issue":"5","key":"10.1016\/j.placenta.2025.04.026_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10719-007-9090-8","article-title":"Is human placenta proteoglycan remodeling involved in pre-eclampsia?","volume":"25","author":"Warda","year":"2008","journal-title":"Glycoconj. J."},{"issue":"6","key":"10.1016\/j.placenta.2025.04.026_bib39","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/molehr\/8.6.566","article-title":"Localization of heparanase in normal and pathological human placenta","volume":"8","author":"Haimov-Kochman","year":"2002","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.placenta.2025.04.026_bib40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2020.00570","article-title":"HS and inflammation: a potential playground for the sulfs?","volume":"11","author":"El Masri","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.placenta.2025.04.026_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jlb.66.3.391","article-title":"Modulation of macrophage and B cell function by glycosaminoglycans","volume":"66","author":"Wrenshall","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.placenta.2025.04.026_bib42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fimmu.2020.00769","article-title":"Proteoglycans in obesity-associated metabolic dysfunction and meta-inflammation","volume":"11","author":"Pessentheiner","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:18:07Z","timestamp":1768389487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"alternative-id":["S0143400425001377"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.04.026","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal serum heparan sulfate in preeclampsia pathophysiology: Insights from a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}